Abstract Previously we reported that intermittent calorie restriction (ICR) provided greater prevention of mammary tumors (MTs) than chronic calorie restriction (CCR). Here the impact of increased fat intake during refeeding in an ICR protocol was evaluated. MMTV-TGF-a female mice were assigned to one of three groups: ad libitum (AL) fed (n = 45) with free access to a moderately high fat diet (22 % fat calories); ICR (n = 45) 50 % calorie restricted for 3-week intervals followed by 3 weeks of 100 % of AL intake; and CCR (n = 45) fed 75 % of AL mice, matching each 6-week cycle of ICR mice. ICR mice were further designated as ICR-Restricted or ICR-Refed for data obtained during these intervals. All mice consumed the same absolute amount of dietary fat. Mice were followed to assess MT incidence, body weight and serum IGF-1, IGFBP3, leptin and adiponectin levels until 79 (end of final 3-week restriction) or 82 (end of final 3-weeks refeeding) weeks of age. Age of MT detection was significantly extended for CCR (74 weeks) and ICR (82 weeks) mice, compared to 57.5 weeks for AL mice. MT incidence for AL, ICR and CCR mice was 66.7, 4.4, and 52.3 %, respectively. Mammary and fat pad weights were reduced significantly following 50 % calorie restriction in ICRRestricted mice compared to AL, CCR and ICR-Refed mice. IGF-1 and leptin levels also tended to be reduced in ICR-Restricted mice over the course of the study while adiponectin was not compared to AL, CCR, and ICR-Refed mice. The adiponectin:leptin ratio was consistently higher following 50 % restriction in ICR-Restricted mice. There was no relationship of IGF-1, leptin, or adiponectin with the presence of MTs in any groups. Thus the manner in which calories are restricted impacts the protective effect of calorie restriction independently of high fat intake.
Introduction
Although improvements in breast cancer treatment continue to be made allowing a majority of women to survive many years after diagnosis, prevention of this disease is still of outmost importance. Towards this goal, women identified to be at increased breast cancer risk based on the Gail Score have been offered tamoxifen treatment and more recently raloxifene for prevention. However, these pharmaceutical agents have undesirable side effects and many women refuse treatment or discontinue it. Also other factors not evaluated in the Gail Score for example obesity or adult weight gain also increase risk. This has led to recommendations for women to lose weight if obese or to prevent weight gain to decrease their risk.
Although human studies are limited as to actual documentation that weight loss or prevention of weight gain will reduce breast cancer risk [1] in animal models calorie restriction consistently prevents the development of mammary tumors (MTs). In most cases, chronic calorie restriction (CCR) protocols have been used whereby the same degree of calorie restriction is used on a daily basis. This approach has been consistently reported to prevent or delay the development of spontaneous and carcinogeninduced MTs [2] [3] [4] [5] [6] [7] [8] . Interestingly, the consumption of high fat diets during CCR protocols did not alter the protective effect of this intervention [9] [10] [11] [12] . In contrast, ad libitum (AL) consumption of high fat diets shortened latency and/ or increased the incidence of spontaneous and carcinogeninduced MTs [13] . Further, we have reported that transgenic mouse mammary tumor virus transforming growth factor-a (MMTV-TGF-a) mice fed a moderately high fat diet (32.5 % fat calories) that gained weight and became obese, i.e., obesity-prone mice had a shortened tumor latency compared to mice fed a low fat diet [14] . Interestingly, mice fed the same high fat diet that did not gain weight, i.e., obesity-resistant, had shorter MT latency than did low fat mice. Thus, the impact of dietary fat content on MT development may be dependent upon whether AL or calorie restriction is utilized.
Although CCR is the most widely implemented protocol for MT prevention, a few investigators have evaluated the impact of intermittent calorie restriction (ICR) on MT development. For example, fasting/refeeding regimens have been reported to reduce MT incidence in comparison to AL feeding [15] [16] [17] . However, in one case, it appeared that fasted/ refed C3H/Ou mice fed a high fat diet developed more spontaneous MTs compared to a fasted/refed group fed a low fat diet [16] . Further, two different ICR protocols implemented in rats fed high fat diets did not provide protection against the development of carcinogen-induced MTs [18, 19] .
More recently we have reported that multiple cycles of 3 weeks of 50 % caloric restriction followed by 3 weeks of refeeding reduced the incidence of MTs in two transgenic mouse strains, MMTV-TGF-a [20] [21] [22] and MMTV-neu [23] , to a greater extent than did the same degree of calorie restriction implemented by CCR. The diets used were based on AIN-93M formulations providing *9 % fat calories to AL-fed mice. Here, we used the ICR protocol to determine how a higher fat intake affected this protective effect of ICR. We also evaluated the influence of consumption of a higher fat diet on serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) as previously MMTV-TGF-a mice with MTs had higher terminal IGF-1 and lower IGFBP-3 serum levels than did mice without MTs regardless of dietary intervention and the elevated IGF-I levels were present prior to tumor detection. [22] .
Another aspect of our investigation was to measure the serum adipokines, leptin and adiponectin, which are synthesized and secreted from adipose tissue and have been implicated in breast cancer development [24] [25] [26] . For example, in in vitro experiments addition of leptin enhanced proliferation of human breast cancer cell lines [27] [28] [29] [30] [31] ; while in contrast, adiponectin reduced breast cancer cell proliferation [32] [33] [34] [35] . Further findings from two human studies [36, 37] and from our in vitro study which evaluated the impact of different adiponectin:leptin ratios on human breast cancer cell proliferation [38] suggested that the adiponectin:leptin ratio may be more important in determining how these two proteins affect MT development than either alone. In support, in both longitudinal and cross-sectional studies, we have shown that the ICR protocol was associated with an elevated adiponectin:leptin ratio in relationship to reduced tumor incidence of MMTV-TGF-a mice [39, 40] .
We report here that even when mice were fed a high fat diet during refeeding that the ICR protocol still was more protective than CCR in this model of hormone-responsive breast cancer.
Materials and methods

Animals and study design
MMTV-TGF-a female mice that overexpress human TGFa were produced at the Hormel Institute (Austin, MN, USA) and genotyped as previously described [20] . At 8 weeks of age, mice were housed individually and provided AL access to water and powdered AIN-93M diet. At 10 weeks of age, mice were assigned to AL, CCR, or ICR groups. Mice in the AL group (N = 45) had free access to a 22.7 % fat by calories diet. For the ICR protocol during each 3-week period of restriction ICR mice (N = 45) were provided a diet 19 % fat by calories and fed at 50 % of the consumption level of AL mice and in each 3-week refeeding period were provided with a 33.6 % fat by calories diet at 100 % of food intake of age-matched AL mice. CCR mice (N = 45) were given a 29.6 % fat by calories diet formulated to match the calorie/nutrient intake of ICR mice for each 6-week cycle when given at 75 % of agematched AL consumption. Formula and nutrient information of all research diets are presented in Table 1 . The goal was that ICR and CCR mice consumed the same absolute amounts of fat and other nutrients except for carbohydrate in comparison to the AL mice.
Food intakes were determined daily and body weights weekly at which time mice were palpated for MTs. Once detected, MT growth was monitored with calipers. All mice were euthanized by CO 2 overdose at predetermined endpoints of either 79 (end of restriction) or 82 (end of refeeding) weeks of age or when MT size exceeded 20 mm in length or the mouse lost more then 25 % of its body weight. When results are presented for ICR mice during restriction periods they are further classified as ICRRestricted and during refeeding periods as ICR-Refed.
Tissue sample collection and histopathological analysis At sacrifice, fat pads (mammary, retroperitoneal, and parametrial), livers, MTs and any abnormally appearing organs or tissues were removed and weighed. A sample of each was placed in 10 % neutral buffered formalin. The remaining tissues were stored at -70°C. Left mammary fad pads, mammary tissue, MTs, and samples that appeared abnormal were sent to the Department of Pathology and Laboratory Medicine of the Mayo Foundation (Rochester, MN, USA) for histopathological analyses to determine malignancy and/or disease status.
Serum measurements
Over the course of the study (10 weeks = baseline and cycles 5, 8, and 11) blood samples were obtained from three cohorts corresponding to the first, second, and third weeks of the restriction and refeeding periods of ICR mice. For each mouse, two samples were obtained per cycle such that for cohort one a sample was obtained corresponding to the first week of restriction and the first week of refeeding (week 1 and 4 of the cycles 5, 8, 11), for cohort two after 2 weeks of restriction and 2 weeks of refeeding (week 2 and 4 of the cycles 5, 8, 11) and cohort three after 3 weeks of restriction and 3 weeks of refeeding (week 3 and 6 of the cycles 5, 8, 11) . Also terminal blood samples were collected from all mice at death. Blood samples were obtained under anesthesia from the orbital sinus. Serum samples were stored at -20°C. IGF-1 was measured using mouse/rat IGF-1 ELISA (DSL-10-29200, Diagnostic Systems Laboratory, Webster, TX) kits. Serum IGFBP-3 levels were determined using a commercial human IGFBP-3 ELISA kit (DSL-10-6600, Diagnostic Systems Laboratory, Webster, TX). Leptin was measured using the mouse Leptin ELISA kit (EZML-82K, Linco Research, St. Charles, MO). Serum adiponectin levels were determined using a mouse Adiponectin ELISA kit (EZML-60K, Linco).
Statistical analysis
Results are presented as mean ± standard error of the mean (SEM). Serum data were analyzed by ANOVA followed by Neuman-Keuls test or t test. Number of MTs per mouse, MT incidence, and grade were analyzed by the Chi squared and two-group log-rank test. Kaplan-Meier analysis was used for evaluation of time of tumor detection. Graph Pad Prism version 4 was used for statistical analysis.
Results
Food intake
As expected based from the experimental design cumulative energy intakes were lower for CCR (6038 ± 11 kcal/mouse, 22 % reduction) and ICR (6131 ± 11 kcal/mouse, (21 % reduction) mice, respectively, compared to AL mice (ANOVA P \ 0.0001, ICR and CCR P \ 0.001 versus AL). The total calorie intake of the AL mice was 7,766 ± 99 kcal/mouse. However, cumulative fat intakes were similar, 194 ± 2, 196 ± 0.4, and 195 ± 0.4 g for AL, CCR, and ICR groups, respectively.
Body and fat pad weights
Body weights over the course of the study are presented in Fig. 1 . The body weight curve for AL mice was significantly higher than for CCR and ICR mice (P \ 0.001). ICR mice exhibited a pattern of weight loss during caloric restriction periods followed by rapid weight regain during the first week of refeeding. Terminal body and fat pad weights are presented in Fig. 2 . At euthanasia ICRRestricted mice had body and fat pad weights significantly less than AL (P \ 0.001), CCR (P \ 0.001), and ICRRefed (P \ 0.01) mice. In addition, AL mice had significantly heavier body weights than CCR (P \ 0.05) mice, while CCR and ICR-Refed mice had similar body weights (Fig. 2a ). There were no significant differences in mammary ( Fig. 2b ) and internal ( Fig. 2c ) fat pad weights among AL, CCR, and ICR-Refed mice which were all significantly heavier than those of the ICR-Restricted mice.
Pathology Four mice died from unknown illnesses (three AL and one CCR) prior to the age when MTs usually develop, i.e., 39 weeks of age, and were removed from further consideration. Tumor incidence of 66.7 % for AL mice (28/42) was the highest, followed by 52.3 % for CCR mice (23/44), and 4.4 % for ICR mice (2/45) was the lowest (Table 2 ). All groups were significantly different from each other.
Tumors become palpable at age 45 weeks in AL mice, 52 weeks in CCR mice. Two MTs found in ICR mice were not palpable and only detected following necropsy at 82 weeks of age with one tumor visual and the second identified as a focus of adenocarcinoma in the mammary fat pad by the pathologist. Kaplan-Meier analysis revealed a significant difference among AL, CCR, and ICR groups in time of tumor detection (P \ 0.0001, Fig. 3 ). It should be noted that the due to the limited tumors obtained for the ICR mice number of tumors per mouse and tumor weight were not included in statistical analysis. Tumor-bearing AL mice developed between 1 and 5 MTs per mouse, while CCR mice had 1 to 3 (P \ 0.0001). Interestingly CCR mice had significantly higher MT weight than did AL mice. A summary of MT histopathology is presented in Table 2 . A total of 40 tumors were identified in 28 AL mice, 39 tumors in 23 CCR mice, and 2 tumors in two ICR mice. The majority of the MTs regardless of dietary group were classified as grade 2 and 3 adenocarcinomas with others classified as either Grade 4 or low grade (adenocarcinomas/carcinomas in situ). In eight mice, additional benign or malignant growths were noted. One AL, two ICR, and three CCR mice had myeloproliferative disorder. There were two AL mice with ovarian tumors (one a low grade adenocarcinoma and other was benign). In addition, non-malignant pathology of ovaries, hemorrhagic corpus luteus cyst was detected in one AL, one CCR and two ICR mice. Terminal IGF-1 and IGFBP-3 serum levels At euthanasia ICR-Restricted mice had serum IGF-1 levels significantly lower than AL (P \ 0.01) and ICR-Refed (P \ 0.05) mice (Fig. 4a ). There were no significant differences in terminal IGF-1 concentrations among AL, CCR and ICR-Refed mice or between CCR and ICR-Restricted mice. ICR-Restricted mice had significantly higher IGFBP-3 serum level than did AL (P \ 0.01) and CCR (P \ 0.05) mice, while there was no statistical difference (P [ 0.05) for terminal IGFBP-3 among the AL, CCR, ICR-Refed mice or between ICR-Restricted and ICR-Refed mice (Fig. 4b) . ICR-Restricted mice also had a serum IGF-1:IGFBP-3 ratio (Fig. 4c) significantly lower than AL (P \ 0.001) mice. There were no significant differences for the IGF-1:IGFBP-3 ratio between ICR-Refed, CCR, and AL mice and also between ICR-Refed, CCR, and ICRRestricted mice.
Correlations between IGF-1, IGFBP-3, IGF-1:IGFBP-3 ratio and body and fat pad weight measurements were done (not shown). In general, serum IGF-1 concentrations of all mice positively correlated with terminal body weight (P = 0.0495, r = 0.1798, number of XY pairs-120, but not with mammary and internal fad pad weights (not shown). There were no correlations of weight parameters with either terminal IGFBP-3 concentration or the IGF-1:IGFBP-3 ratio. Interestingly, when all mice that developed MTs were considered together there was no statistical difference in terminal IGF-1 or IGFBP-3 between tumor-free and tumor-bearing mice, however mice with MTs had significantly higher IGF-1:IGFBP-3 than mice without MTs (t test: P = 0.0133).
Longitudinal IGF-1 serum levels
Samples for prospective serum IGF-1 evaluation were obtained when mice were enrolled (baseline, 10 weeks old) and during cycles 5 (34-39 weeks old), 8 (52-57 weeks old), and 11 (72-75 weeks old) as described in the ''Materials and methods'' section. Baseline IGF-1 concentration was 379.26 ± 17.64 ng/ml (Fig. 5) . For AL and CCR mice, there were little differences in values obtained over the 6-week periods and these results were combined. For the ICR mice values were combined for 3 weeks of restriction and 3 weeks of refeeding. As shown in Fig. 5 , while IGF-1 serum concentration for CCR mice were maintained at baseline level with increasing age, AL mice had slightly increased IGF-1 reaching significance in Cycle 8 (P \ 0.01). ICR-Restricted mice consistently had significantly lower IGF-1 levels compared with both their refeeding (P \ 0.001) and baseline (P \ 0.001) measurements. The most dramatic change in IGF-1 concentrations between restriction and refeeding periods for ICR mice was in Cycle 8 when the IGF-1 value was statistically higher in refeeding (P \ 0.05) and lower in restriction (P \ 0.001) in comparison with the baseline level. Over the course of the study there were no significant differences in IGF-1 serum levels between mice that eventually developed tumors compared to those that did not in any groups (data not shown).
Terminal adiponectin and leptin serum levels
At euthanasia serum adiponectin levels were similar among the groups (Fig. 6a) . Serum leptin was reduced in the ICRRestricted mice by 75 % compared to the other three groups but did not reach statistical significance, probably due to the small sample size (Fig. 6b) . At euthanasia, ICRRestricted mice had serum adiponectin:leptin ratio significantly higher than CCR (P \ 0.01), ICR-Refed (P \ 0.01), and AL (P \ 0.01) mice (Fig. 6c ). There were We also examined the correlations between adiponectin, leptin, adiponectin:leptin ratio, and body and fat pad weights (not shown). Terminal leptin serum concentration of all mice positively correlated with final body weights (P \ 0.0001, r = 0.67, number of XY pairs-51), mammary fat pad weights (P \ 0.0001, r = 0.73, number of XY pairs-50) and internal fat pad weights (P \ 0.0001, r = 0.67, number of XY pairs-50). In contrast, terminal serum adiponectin concentration and adiponectin:leptin ratio were not correlated with body weights, mammary and internal fad pad weights. We also did not find significant differences in adiponectin, leptin, or adiponectin:leptin ratio serum levels between AL, CCR, and ICR tumorbearing and tumor-free mice (data not shown).
Longitudinal adipokines serum levels
One of our goals was to evaluate serum adipokine concentrations over the course of the study. Baseline adiponectin concentration was 5.90 ± 0.32 lg/ml (Fig. 7a) . Serum adiponectin increased over time in comparison to baseline for all dietary groups (P \ 0.001) except AL mice in Cycle 11 (P \ 0.05). Interestingly, whereas CCR mice reached a significantly higher adiponectin level than did AL mice in Cycle 11 (P \ 0.05), ICR-Restricted mice already had statistically higher adiponectin level than AL mice in Cycle 8 (P \ 0.01) which was maintained thereafter (P \ 0.05). Further, while ICR-Restricted mice had significantly higher adiponectin serum concentration in comparison to ICR-Refed mice only in Cycle 5 (P \ 0.01) it is important to note that ICR-Restricted mice had significantly higher adiponectin serum levels across the study in comparison to CCR mice (P \ 0.01 for Cycles 5 and 8 and P \ 0.05 for Cycle 11). Baseline level of leptin at 10 weeks of age was 0.65 ± 0.10 ng/ml (Fig. 7b) . Serum leptin concentrations increased for AL, CCR, and ICR-Refed mice over the study in comparison to baseline (P \ 0.01 in Cycle 5 and P \ 0.001 in Cycles 8 and 11). However, in contrast to adiponectin, in each cycle ICR-Restricted mice had leptin levels similar to the baseline level. Over the course of the study AL mice had the highest serum concentrations (P \ 0.001 versus all groups in all cycles. This was followed by CCR and ICR-Refed mice with similar leptin values. The ICR-Restricted mice had the lowest leptin serum levels in every cycle. We also calculated adiponectin:leptin ratio over the course of the study (Fig. 7c) . As can be seen AL, CCR, and ICR-Refed mice had reduced values in all cycles, while there was elevated in ICR-Restricted mice compared to the baseline levels. Within each cycle values were similar for AL, CCR, and ICR-Refed mice and statistically lower than those calculated for ICR-Restricted mice. Over the course of the study, there were no significant differences in adiponectin and leptin serum levels or in adiponectin:leptin ratio values between AL, CCR, and ICR tumor-bearing and tumor-free mice (data not shown).
Discussion
Here we report that when dietary fat content is increased ICR still resulted in far superior protection in the prevention of MT development than did the same degree of calorie restriction implemented in a chronic fashion. These results complement earlier findings that consistently indicated the ICR reduced MT incidence and extended latency in MMTV-TGF-a mice fed a low fat diet in comparison to mice fed the same reduced calories (and other nutrients) chronically [20] [21] [22] 40] .
A protective effect of fasting/refeeding on spontaneous mammary tumor development has also been reported although comparison to CCR was not done [16, 17, 41, 42] . In one case, mice fed a high fat diet appeared to develop more spontaneous MTs than did those fed a low fat diet but overall the degree of protection was still very significant compared to the AL fed mice [16] . In contrast, it appeared that there was not a protective effect of intermittent restriction protocols using high fat diets introduced near the time of carcinogen administration on the development of this type of MTs [18, 19] . However, when the ICR intervention was started several months after carcinogen administration MT incidence was reduced by 50 % compared to AL fed rats [43] . In light of other studies reporting that fasting/refeeding at the time of carcinogen administration may enhance tumorigenesis this suggests that the results of the two former studies were due to timing of the intervention rather than the consumption of a high fat diet per se. We have also reported that MMTV-neu mice that develop estrogen receptor negative MTs had reduced incidence following ICR compared to both AL and CCR mice [23] .
Although limited in number there are additional reports of that ICR provides protection in other malignancies. For example, ICR implemented in the TRAMP mouse model of prostate cancer in a 2-week restriction/2-week refeeding protocol from 7 to 50 weeks of age resulted in delayed prostate tumor detection and death, while there was little effect of CCR in comparison to AL-fed TRAMP mice [44, 45] . In mice with xenografts resulting from inoculation of a human prostate cancer cell line subjected to several different ICR regimens survival was improved by either 1 or 2 days of fasting per week with controlled refeeding for the remainder of the week [46] . In several different lymphoma models, ICR reduced disease incidence even when the intervention was initiated in older animals [47, 48] .
There has also been interest in the impact of weight fluctuation and how it might affect breast cancer development. In a retrospective study of postmenopausal women with a history of weight cycling, no association of weight cycling with breast cancer development was found [49] . However, several studies reported that women diagnosed with anorexia nervosa who likely experienced periods of weight loss and regain were at reduced risk for breast cancer [50, 51] .
Results of an intervention study which compared the effects of CCR versus ICR in overweight women identified at high risk for breast cancer have recently been published [52] . The overall calorie restriction was 25 % with weight reduction similar between the groups as were most of the measurements made. Interestingly, when the authors combined the fasting insulin and glucose values to calculate the insulin resistance index using the HOMA (homeostatic model assessment), they found that it was reduced to a greater extent compared to starting values in the ICR versus CCR group. This indicates that the ICR group had a reduction in insulin resistance compared to the CCR group. A slight decrease in the leptin:adiponetin ratio was also found. A follow-up study by these researchers (M. Harvie personal communication) compared three types of calorie restriction diets in a similar population of women in a 4 month protocol. Women were assigned to either a restricted low carbohydrate diet 2 days a week, an AL low carbohydrate diet 2 days a week or a standard daily restricted Mediterranean diet 7 days a week. With respect to weight loss and HOMA measurements, the two ICR diets were superior to the CCR approach. Although these studies do not include breast cancer as an outcome, they clearly demonstrate the feasibility of implementing this approach in humans.
Epidemiological [53] [54] [55] and rodent [56, 57] studies have shown that elevated levels of IGF-1 are associated with increased risk of breast/mammary cancer. Further, energy-restricted diets significantly reduce levels of circulating IGF-1 in rodents [21, 58, 59] . Previously, we found that CCR [20, 21] and ICR-Restricted [21] transgenic MMTV-TGF-a mice had reduced terminal IGF-1 levels compared with AL-fed mice and lower serum IGF-1 levels were associated with the prevention of MTs after long term CCR [20, 21] . In a more recent study, terminal IGF-1 serum levels of ICR mice were significantly lower after both 3 weeks of restriction and 3 weeks of refeeding compared to AL and CCR groups and mice with MTs had higher terminal IGF-1 and lower IGFBP-3 levels than mice without tumors regardless of whether they were AL-fed or calorie restricted [22] . In this study, there was less impact on terminal IGF-I levels as a result of reduced calorie intake. However, IGFBP-3 levels tended to be higher which was reflected by a reduction in the IGF-I:IGFBP-3 ratio. We also did not find significant differences in IGF-1 serum levels between AL, CCR, and ICR mice with or without MTs, although we again found that mice that developed MTs had significantly higher IGF-1:IGFBP-3 ratio than mice without tumors. These results may at least in part be due to the higher dietary fat content and this issue remains to be investigated in more detail.
We have investigated the adipokines, leptin, and adiponectin because of their potential roles in tumorigenesis. As cited in the ''Introduction'', in vitro experiments indicate that leptin enhances breast cancer cell proliferation while adiponectin reduces it. In women, serum leptin has not been consistently found to be elevated in those with postmenopausal breast cancer as reviewed in [60] However, adiponectin has been reported to be reduced in women with breast cancer compared to those without [37, 61, 62] and in several studies the ratio of adiponectin:leptin was reduced in women with breast cancer [35, 36] . We have published in vitro studies indicating the importance of this ratio in cell proliferation of both breast and prostate cancer cell lines [38, 63] . Further, in both a prospective and a cross-sectional study we reported that periods of 50 % calorie restriction resulted in a high adiponectin:leptin ratio which is not observed with 25 % calorie reduction [39, 40] . In those studies, a low fat diet was used. Here, we show that this relationship is also observed in association with a higher fat intake. Thus, we consistently find an increase in the adiponectin:leptin ratio associated with an intervention that reduced MT incidence. Interestingly women on an ICR protocol for 6 months had a reduced leptin:adiponectin ratio or if calculated differently an increased adiponectin:leptin ratio compared to women fed the same reduced calorie intake in a chronic fashion [52] .
Conclusions
In summary, we demonstrate that even when mice were fed a high fat diet during refeeding, the ICR protocol was still more protective than CCR with respect to the prevention of MTs. While a higher fat consumption did not eliminate the protective effect of CCR, it did result in an increased tumor burden and the protection was not as robust as seen in our earlier studies using a low fat diet. The two modes of calorie restriction had different influences on serum IGF-1 and adipokine levels and on their ratios. While values of IGF-1, IGFBP-3 and IGF-1:IGFBP-3 ratio of CCR mice were similar with those obtained for AL mice, IGF-1 levels of ICR mice during restriction periods were consistently lower than during refeeding and in comparison to CCR and AL levels. ICR-Restricted mice also had higher terminal IGFBP-3 and lower IGF-1:IGFBP-3 ratio in comparison with AL mice. Mice in AL, CCR and ICR-Refed groups had raised adiponectin and leptin values in comparison to baseline concentrations and AL mice had significantly higher leptin serum levels over the study period in comparison to all dietary groups. The significantly reduced tumor incidence in ICR mice was associated with an elevated terminal serum adiponectin:leptin. In addition when mice from all dietary groups which developed MTs were considered together they had significantly higher IGF-1: IGFBP-3 than mice without tumors. These findings support considering ways to implement dietary intervention that may alter the course of breast tumor development in at risk women.
